Scarica l'app Stockscreener
4.335
6.65%
0.275
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MXCT Giù?
Forum
Previsione
Maxcyte Inc Borsa (MXCT) Ultime notizie
MaxCyte Signs Strategic Platform License With Kamau Therapeutics To Accelerate the Development of Cell Therapies for Genetic Diseases - Technology Networks
Bank of New York Mellon Corp Has $1.66 Million Stock Holdings in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
MaxCyte and Kamau Therapeutics sign platform license agreement - Pharmaceutical Technology
MaxCyte and Kamau Therapeutics sign platform license agreement - Yahoo Finance
MaxCyte enters licence agreement with Kamau Therapeutics - ShareCast
MaxCyte Signs Strategic Platform License with Kamau Therapeutics to Accelerate the Development of Cell Therapies for Genetic Diseases - StockTitan
MaxCyte Signs Strategic Platform License with Kamau Therapeutics to Accelerate the Development - The Bakersfield Californian
MaxCyte Partners with Kamau Therapeutics to Advance Gene Therapies - TipRanks
MaxCyte (LON:MXCT) Stock Passes Below Fifty Day Moving Average of $330.81 - MarketBeat
Zurcher Kantonalbank Zurich Cantonalbank Grows Position in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
MaxCyte Director Executes Options, Sells Shares - TipRanks
MaxCyte Announces Participation in Bioprocessing Conference - TipRanks
MaxCyte (LON:MXCT) Stock Price Passes Below 50-Day Moving Average of $332.41 - MarketBeat
MaxCyte to Participate in Virtual Craig-Hallum Capital Group Bioprocessing Conference - ForexTV.com
Insider Selling: MaxCyte, Inc. (NASDAQ:MXCT) Director Sells 29,767 Shares of Stock - MarketBeat
MaxCyte to Participate in Virtual Craig-Hallum Capital Group Bioprocessing Conference - StockTitan
MaxCyte Inc [MXCT] Officer makes an insider purchase of 143,067 shares worth 0.62 million. - Knox Daily
MaxCyte to Participate in Virtual Craig-Hallum Capital Group Bioprocessing Conference - Morningstar
Exercise of options and PDMR dealing - ShareCast
MaxCyte Director Executes Stock Options and Sells - TipRanks
MaxCyte, Inc. (NASDAQ:MXCT) Director John Joseph Johnston Sells 3,000 Shares - MarketBeat
MaxCyte director Johnston sells shares worth over $12,000 - Investing.com
SG Americas Securities LLC Sells 11,194 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
Recent Insider Activity Suggests Potential Gains for MaxCyte Inc (MXCT) - Knox Daily
MaxCyte (LON:MXCT) shareholders have earned a 22% CAGR over the last five years - Yahoo Finance
Price T Rowe Associates Inc. MD Has $106,000 Stake in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
MaxCyte (LON:MXCT) Stock Price Crosses Below 50-Day Moving Average of $345.70 - Defense World
Does MaxCyte (MXCT) Have the Potential to Rally 85% as Wall Street Analysts Expect? - MSN
Vanguard Group Inc. Has $22.40 Million Holdings in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
FY2024 EPS Estimates for MaxCyte, Inc. (NASDAQ:MXCT) Lifted by William Blair - Defense World
FY2024 Earnings Forecast for MaxCyte, Inc. (NASDAQ:MXCT) Issued By William Blair - MarketBeat
MaxCyte, Inc. (LON:MXCT) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year - Simply Wall St
Market Resilience: MaxCyte Inc (MXCT) Finishes Weak at 4.08, Down -8.31 - The Dwinnex
MaxCyte Inc: Navigating Market Volatility with a 1.79 Debt-to-Equity Ratio - The InvestChronicle
EVP, GLOBAL SALES Ross Thomas M. sale 17,857 shares of MaxCyte Inc [MXCT] - Knox Daily
MaxCyte (NASDAQ:MXCT) Posts Quarterly Earnings Results, Beats Estimates By $0.05 EPS - MarketBeat
Earnings call: MaxCyte sees stable Q2 revenue, maintains cautious outlook By Investing.com - Investing.com Canada
Earnings call: MaxCyte sees stable Q2 revenue, maintains cautious outlook - Investing.com
MaxCyte, Inc. (NASDAQ:MXCT) Q2 2024 Earnings Call Transcript - Insider Monkey
MaxCyte reports solid second-quarter performance - ShareCast
Filing of Form 10-Q - ShareCast
MaxCyte, Inc. (MXCT) Q2 2024 Earnings Call Transcript - Seeking Alpha
MaxCyte, Inc. (MXCT) Reports Q2 Loss, Tops Revenue Estimates - MSN
MaxCyte, Inc. (MXCT) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
MaxCyte Updates Corporate Presentation for Investor Insight - TipRanks
MaxCyte Reports Second Quarter and Half-Year 2024 Financial Results and Updates Full Year 2024 Guidance - wallstreet:online
MaxCyte Reports Second Quarter and Half-Year 2024 Financial Results and Updates Full Year 2024 Guidance - Yahoo Finance
MaxCyte Reports Second Quarter and Half-Year 2024 Financial Results and Updates Full Year 2024 Guidance - Afternoon Headlines
Do investors need to be concerned about MaxCyte Inc (MXCT)? - US Post News
MaxCyte, Inc. (NASDAQ:MXCT) EVP Thomas M. Ross Sells 15,476 Shares - MarketBeat
MaxCyte Reports Second Quarter and Half-Year 2024 Financial Results and Updates Full Year 2024 Guidance - StockTitan
MaxCyte Flow Electroporation For Gram-Scale Transient Antibody Production In CHO-S Cells - BioProcess Online
MaxCyte (LON:MXCT) Stock Crosses Above Fifty Day Moving Average of $349.25 - Defense World
Russell Investments Group Ltd. Buys New Stake in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
Swedbank AB Invests $6.70 Million in MaxCyte, Inc. (NASDAQ:MXCT) - MarketBeat
MaxCyte Issues New Shares, Updates Capital - TipRanks
The ExPERT VLx System™Superior Transfection Scalability And Efficiency - BioProcess Online
MaxCyte, Inc. (NASDAQ:MXCT) Shares Bought by Lazard Asset Management LLC - Defense World
MaxCyte Inc (MXCT) receives a Buy rating from Craig Hallum - Knox Daily
MaxCyte, Inc. (NASDAQ:MXCT) Director John Joseph Johnston Sells 3,000 Shares - Defense World
MaxCyte Director Executes Stock Options and Sells Shares - TipRanks
MaxCyte, Inc. (NASDAQ:MXCT) Shares Sold by EntryPoint Capital LLC - Defense World
McGrath RentCorp (NASDAQ:MGRC) Shares Acquired by O Shaughnessy Asset Management LLC - Defense World
MaxCyte (MXCT) to Release Earnings on Tuesday - MarketBeat
MaxCyte (MXCT) Scheduled to Post Earnings on Tuesday - Defense World
0.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):